Patent ID: 8192768

Claim:
A composition for treating 5-lipoxygenase mediated diseases and free radical mediated diseases comprising an effective amount of a Boswellia serrata extract containing 3-O-acetyl-11-keto-β-boswellic acid (AKBA) and an effective amount of enriched demethylated curcuminoids obtained from a Curcuma longa extract, said compositions optionally containing at least one of: a) a compound selected from the group consisting of glucosamine, resveratrol, garlic extract, ginger extract, chondroitin, methylsulfonylmethane, bromelain, serratia peptidase, quercitine, and mixtures thereof, b) natural antioxidants selected from the group consisting of gallic acid, caffeic acid, green tea extract, and mixtures thereof, and c) non-steroidal anti-inflammatory agents selected from the group consisting of aspirin and ibuprofen, said demethylated curcuminoids comprising from 15% to 100% by weight of at least one compound selected from the group consisting of compounds of Formula 1, Formula 2, Formula 3 and Formula 4: